# Allogene Therapeutics, Inc.: Form 8-K, filed Oct 14, 2025

- Company: [Allogene Therapeutics, Inc.](/companies/allo.md) (CIK 1737287)
- Form: 8-K
- Filed: 2025-10-14
- Accepted by EDGAR: Oct 10, 2025, 17:31 ET
- Period: 2025-09-26
- Accession: 0001628280-25-044828
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1737287/000162828025044828/allo-20250926.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1737287/000162828025044828/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1737287/000162828025044828/allo-20250926.htm

Filed Oct 14, 2025.
Source: SEC EDGAR, the filing index for accession 0001628280-25-044828. Last ingested by Listed: Oct 27, 2026, 17:28 ET. No prices; not investment advice.